APRILLUS

Ciudad Autonoma Buenos Aires C1194AAN

0 studies enrolling now · 6 studies all time

What they study most

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis — Completed
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis — Stopped early
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed